Free Trial

Vor Biopharma (VOR) SEC Filings & 10K Form

Vor Biopharma logo
$0.70 +0.01 (+1.30%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$0.73 +0.03 (+4.29%)
As of 04/15/2025 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vor Biopharma SEC Filings

DateFilerForm TypeView
03/31/2025
11:15 PM
Vor Biopharma (Filer)
Form EFFECT
03/28/2025
3:33 PM
Vor Biopharma (Filer)
Form PRE 14A
03/20/2025
3:45 PM
Vor Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2025
3:48 PM
Vor Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
3:01 PM
Vor Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
3:29 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:34 AM
FMR LLC (Filed by)
Vor Biopharma (Subject)
Form SCHEDULE 13G/A
02/07/2025
3:35 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:36 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:37 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:01 PM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
8:19 PM
Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:20 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:22 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:23 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
11:15 PM
Vor Biopharma (Filer)
Form EFFECT
01/29/2025
4:24 PM
Vor Biopharma (Filer)
Form 424B3
01/21/2025
3:24 PM
Vor Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2025
5:39 PM
Kalir Erez (Reporting)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:41 PM
Kalir Erez (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
8:06 AM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:53 PM
Reprogrammed Interchange LLC (Filed by)
Vor Biopharma (Subject)
Form SCHEDULE 13D
01/02/2025
6:37 PM
Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
6:42 PM
Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:15 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
5:51 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Vor Biopharma (Subject)
Form SCHEDULE 13D/A
12/30/2024
5:52 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:17 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2024
8:05 AM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
6:39 AM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:33 PM
Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma (Subject)
Form SC 13G/A
11/08/2024
3:15 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:15 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:15 PM
Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:20 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
3:16 PM
Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
3:17 PM
Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The Crypto Market is About to Change Lives (Ad)

I've discovered something so significant about the 2025 crypto market that I had to put everything else aside and write a book about it. This isn't just another Bitcoin prediction – it's a complete roadmap for what I believe will be the biggest wealth-building opportunity of this decade. The evidence is so compelling, I'm doing something that probably seems insane: I'm giving away my entire book for free.

Claim your FREE copy of my controversial book before I change my mind.
09/30/2024
6:05 AM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:06 PM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:01 PM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:29 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:30 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:04 PM
Jorgensen Nathan D. (Reporting)
Vor Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
4:22 PM
Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/04/2024
5:09 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:38 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
3:54 PM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:10 PM
Lundberg Sven Ante (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:10 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:10 PM
Patterson Matthew R (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:10 PM
Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:40 PM
Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:39 PM
Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:VOR) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners